Investor Backing & Capital Strength:
Recent financing at a sharply higher valuation, including strategic healthcare investors, signals strong external confidence and ample resources for scale. Management’s stated expansion plans and partnerships indicate capital is being deployed toward R&D and international growth.
Strong Revenue Growth:
Company-reported bookings grew significantly year over year and aligned third‑party estimates indicate an exit run rate around the billion‑dollar level. These signals point to robust top‑line momentum heading into 2026.
Healthy Cash Flow:
Management reported operating cash‑flow positivity in 2025. Positive cash generation alongside growth supports increased operating flexibility.
